Nitroglycerin Patch Suppliers & Bulk Manufacturers
Available Forms: Patches
Available Strengths: 0.1 mg/hr, 0.2 mg/hr, or 0.3 mg/hr
Reference Brands: Nitro-Dur, Minitran, Nitrogard
Category:
Transdermal Patches
Nitroglycerin patches deliver continuous transdermal nitrate absorption, relaxing vascular smooth muscle by increasing nitric oxide levels. They effectively prevent angina attacks, reduce chest pain, and improve cardiac oxygen supply. Benefits include steady symptom control, enhanced patient compliance, reduced acute episodes, and improved quality of life with proper use.
Nitroglycerin Patch is available in Patches
and strengths such as 0.1 mg/hr, 0.2 mg/hr, or 0.3 mg/hr.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Nitroglycerin Patch is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Nitroglycerin Patch can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Nitroglycerin patches in the EU and US are regulated to ensure safety, efficacy, and quality. In the US, FDA approval involves validation, safety monitoring, and GMP compliance, supported by clinical data. In the EU, CE marking certifies conformity with MDR standards. Both regions require validation, stability testing, and audits, with comprehensive documentation including safety profiles, clinical performance data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, reliable transdermal nitroglycerin patches, supporting effective angina management, reducing cardiovascular risks, and improving patient outcomes worldwide through regulated, high-quality medical products.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing